← Eichor
Study identifier: NCT05764044 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Adjuvant Chemotherapy in cfHPV-DNA Plasma Positive Patients: A Biomarker In Locally Advanced Cervical Cancer

Condition: Cervical Cancer · Cervix Cancer · Cervix Neoplasm  ·  Sponsor: Hospital do Coracao

PhasePhase 3
Planned participants365
Who can joinFemale, 18 Years to 70 Years
Healthy volunteersNo

About this study

This study hypothesizes that patients who persist with cell-free human papillomavirus deoxyribonucleic acid (cfHPV-DNA) plasma expression at the end of standard treatment, can derive the benefit of using adjuvant chemotherapy in locally advanced cervical cancer (CC). After standard treatment based on concomitant chemoradiotherapy regime, a qualitative and quantitative research of cfHPV-DNA in plasma of patients will be conducted. Patients who have positive research for plasma cfHPV-DNA at the end of chemoradiotherapy treatment will be randomized to receive two additional cycles of adjuvant chemotherapy or observation. Patients will be followed with conduction of computed tomography (CT) scan of the thorax and magnetic resonance (MRI) of abdomen and pelvis and clinical and gynecological examination at every four months.

This description comes directly from the study's public registry record.

Talk to the study team

Michelle S Almeida, PhD  ·  11 999112805  ·  malmeida@hcor.com.br

Rachel H Machado, MCS  ·  11 30536611  ·  rhelena@hcor.com.br

Always discuss trial participation with your own doctor first.

Locations (26)

Centro Integrado de Pesquisa da Amazônia, CINPAMManaus, Amazonas, BrazilRecruiting
Hospital Evangélico de Cachoeiro de ItapemirimCachoeiro de Itapemirim, Espírito Santo, BrazilNot Yet Recruiting
Hospital SamurVitória da Conquista, Estado de Bahia, BrazilNot Yet Recruiting
Hospital de Base do Distrito FederalBrasília, Federal District, BrazilNot Yet Recruiting
Hospital do Câncer de MuriaéMuriaé, Minas Gerais, BrazilRecruiting
Centro de Oncologia de Cascavel, CEONCCascavel, Paraná, BrazilNot Yet Recruiting
União Oeste Paranaense de Estudos e Combate ao Câncer, UOPECCANCascavel, Paraná, BrazilNot Yet Recruiting
Centro Integrado de Oncologia de Curitiba, CIONCCuritiba, Paraná, BrazilNot Yet Recruiting
Instituto Nacional do Câncer, INCARio de Janeiro, Rio de Janeiro, BrazilRecruiting
Liga Norte Riograndense Contra o CâncerNatal, Rio Grande do Norte, BrazilNot Yet Recruiting
Hospital TacchiniBento Gonçalves, Rio Grande do Sul, BrazilNot Yet Recruiting
Hospital Geral de Caxias do SulCaxias do Sul, Rio Grande do Sul, BrazilNot Yet Recruiting

+ 14 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05764044